Oncology & Cancer

Daily texting effectively monitors Rx adherence, side effects

(HealthDay)—For patients with breast cancer receiving endocrine therapy, daily bidirectional text messaging can monitor adherence and adverse events (AEs), according to a study published online May 23 in JCO: Clinical Cancer ...

Oncology & Cancer

Cholesterol lowering Rx cuts recurrence in breast cancer

(HealthDay)—For women with early-stage, hormone receptor-positive invasive breast cancer, initiation of cholesterol-lowering medication (CLM) during endocrine therapy is associated with improved survival and distant recurrence-free ...

Oncology & Cancer

Under and misuse of hormone therapy decreasing, but still high

A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy ...

page 2 from 4